Elevated Neuronal Excitability Due to Modulation of the Voltage-Gated Sodium Channel Nav1.6 by Aβ1−42 by Xi Wang et al.
ORIGINAL RESEARCH
published: 09 March 2016
doi: 10.3389/fnins.2016.00094
Frontiers in Neuroscience | www.frontiersin.org 1 March 2016 | Volume 10 | Article 94
Edited by:
William Cho,
Queen Elizabeth Hospital, Hong Kong
Reviewed by:
Peng Lei,
Sichuan University, China
M. Heather West Greenlee,
Iowa State University, USA
*Correspondence:
Shao Li
lishao89@hotmail.com
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Neurodegeneration,
a section of the journal
Frontiers in Neuroscience
Received: 21 December 2015
Accepted: 24 February 2016
Published: 09 March 2016
Citation:
Wang X, Zhang X-G, Zhou T-T, Li N,
Jang C-Y, Xiao Z-C, Ma Q-H and Li S
(2016) Elevated Neuronal Excitability
Due to Modulation of the
Voltage-Gated Sodium Channel
Nav1.6 by Aβ1–42.
Front. Neurosci. 10:94.
doi: 10.3389/fnins.2016.00094
Elevated Neuronal Excitability Due to
Modulation of the Voltage-Gated
Sodium Channel Nav1.6 by Aβ1−42
Xi Wang 1†, Xiao-Gang Zhang 1†, Ting-Ting Zhou 2, Na Li 1, Chun-Yan Jang 1,
Zhi-Cheng Xiao 3, Quan-Hong Ma 4 and Shao Li 1*
1Department of Physiology, Dalian Medical University, Dalian, China, 2Department of Neurology, the First Affiliated Hospital of
Dalian Medical University, Dalian, China, 3 The Key Laboratory of Stem Cell and Regenerative Medicine, Kunming Medical
College, Institute of Molecular and Clinical Medicine, Kunming, China, 4 Jiangsu Key Laboratory of Translational Research
and Therapy for Neuro-Psycho-Diseases, Institute of Neuroscience, Second Affiliated Hospital, Soochow University, Suzhou,
China
Aberrant increases in neuronal network excitability may contribute to the cognitive deficits
in Alzheimer’s disease (AD). However, the mechanisms underlying hyperexcitability are
not fully understood. Such overexcitation of neuronal networks has been detected
in the brains of APP/PS1 mice. In the present study, using current-clamp recording
techniques, we observed that 12 days in vitro (DIV) primary cultured pyramidal neurons
from P0 APP/PS1 mice exhibited a more prominent action potential burst and a lower
threshold than WT littermates. Moreover, after treatment with Aβ1−42 peptide, 12DIV
primary cultured neurons showed similar changes, to a greater degree than in controls.
Voltage-clamp recordings revealed that the voltage-dependent sodium current density
of neurons incubated with Aβ1−42 was significantly increased, without change in the
voltage-dependent sodium channel kinetic characteristics. Immunohistochemistry and
western blot results showed that, after treatment with Aβ1−42, expressions of Nav and
Nav1.6 subtype increased in cultured neurons or APP/PS1 brains compared to control
groups. The intrinsic neuronal hyperexcitability of APP/PS1 mice might thus be due to an
increased expression of voltage-dependent sodium channels induced by Aβ1−42. These
results may illuminate the mechanism of aberrant neuronal networks in AD.
Keywords: Alzheimer’s disease, beta-amyloid peptide, excitability, voltage-gated sodium channel,
neurodegeneration
INTRODUCTION
Alzheimer’s disease (AD) is the most frequent neurodegenerative disease and a common
cause of dementia in elderly individuals. Various evidence suggests, that β-amyloid (Aβ)
peptides play a causal role in AD’s pathogenesis, but the underlying mechanisms remain
unclear (Palop and Mucke, 2010). In prodromal AD patients, functional MRI has revealed
increased activities in neural networks, rather than loss of activity (Putcha et al., 2011). Other
evidence supports the view, that Aβ-induced excitotoxicity could be critically involved in the
pathogenesis of AD (Ong et al., 2013). In Aβ-induced excitotoxicity, high levels of glutamate
overexcite neurons and cause cell death (Choi, 1988; Olney et al., 1997). Aβ also enhances the
sensitivity of neuron to glutamate, which increases the activity of neuronal networks, resulting
in excitatory potentials and Ca2+ influx (Brorson et al., 1995). However, these changes cannot
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explain patients with early AD frequently alternating between
sober and confused, because synaptic disruption, or regeneration
cannot repeatedly occur within such short time periods. This
phenomenon is more likely due to the abnormal neural network
excitability.
Voltage-gated sodium channels (Nav) play an essential role
in excitable cells. They are necessary components required to
generate and propagate action potentials (Goldin et al., 2000;
Yu and Catterall, 2003; Catterall et al., 2005). The 260 kDa α
subunit is the main component of the voltage-gated sodium
channel. Nine α subtypes, named Nav1.1-Nav1.9, are expressed
in excitable cells (Goldin et al., 2000; Ragsdale, 2008). Among
them, the Nav1.1, Nav1.2, and Nav1.6 subtypes are expressed
in the adult brain and regulate voltage-dependent sodium
currents across the plasma membrane. Nav1.1 is primarily
localized in the neuronal somata of GABAergic neurons (Yu
et al., 2006; Ogiwara et al., 2007). Nav1.2 shows preferentially
high expression in unmyelinated fibers (Ragsdale, 2008). The
Nav1.6 subtype, encoded by the gene SCN8A, is conspicuously
expressed at the nodes of Ranvier and axon initial segments
(Trimmer and Rhodes, 2004). Unique features of Nav1.6 include
its contribution to the persistent current, resurgent current, and
repetitive neuronal firing.
Our previous results showed that Nav1.6 interacts with
amyloid precursor protein (APP), which undergoes abnormal
proteolytic processing to generate Aβ (Xu et al., 2014). APP
also increases the surface expression of sodium channels through
a Go protein-coupled JNK pathway (Liu et al., 2015). Due
to this effect of APP, we hypothesized that the upregulatory
effect of Aβ on neuronal excitability might be partially based
on modulating the expression of sodium channels. As we
expected, in cultured cortical neurons, Aβ1−42 increased the
expression of sodium channels, particularly the Nav1.6 subtype.
The increased voltage-dependent sodium current could decrease
action potential threshold and increase the probability of action
potential generation in response to synaptic excitation, thus
increasing the excitability of the neuron.
MATERIALS AND METHODS
Animals
Newborn C57BL/6J mice were obtained from the Animal Center
of Dalian Medical University. APP/PS1 transgenic mice were
purchased from Jackson Laboratory (stock number 004462)
and were maintained on a C57BL/6J background by crossing
heterozygous transgenic mice with C57BL/6J breeders. All
experiments were conducted in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. All efforts were made to minimize the number of
animals used and their suffering.
Preparation of Aβ1−42
Lyophilized Aβ1−42 peptide (SIGMA, A9810) and reverse peptide
Aβ42−1 (SIGMA, SCP0048) were diluted to 1mg/ml using
sterile PBS and incubated at 37◦C, 220 rpm for 48 h allowed to
aggregate as described (Jones et al., 2013). For concrete forms of
Aβ1−42 peptide, see Supplementary Figure S1. In a further set
of experiments primary cultured neurons were incubated with
Aβ1−42 (5.0µM) or reverse peptide Aβ42−1 (5.0µM) for 24 h at
37◦C.
Cell Culture
P0 (post-natal day 0–1) C57BL/6J mice or APP/PS1 mice and
their littermates were sacrificed by CO2 inhalation and the
cortices were rapidly dissected under sterile conditions in cold
PBS. The tissue was digested with 0.125% trypsin-EDTA at
37◦C for 30min. The trypsin solution was replaced with 2ml
10% DMEM (DMEM with 10% FBS, 1% L-glutamine, and 1%
penicillin/streptomycin solution). The digested tissue was gently
triturated by suction using a glass pipette flamed on the tip to
avoid cellular damage. The cell suspension was filtered through
a 74µm screen mesh, plated on poly-L-lysine-coated coverslips
or 6/12-well-plates and incubated in a 37◦C, 5% CO2 incubator.
After 2 h, themediumwas changed toNeurobasal (Gibco, 21103–
049) supplemented with 2% B27, 1% L-glutamine, and 1%
penicillin/streptomycin. In accordance with the routine culture,
the medium was changed every 2 days until use.
MTT Assay
Cell viability of neurons was determined by the MTT assay.
Neurons were plated in 96 well-plates. Aβ42−1 and Aβ1−42
peptides were added to wells for 24 h. After cell treatments the
medium was removed and the cells were incubated with red free
medium and MTT solution (0.5mg/ml) for 4 h at 37◦C. Finally,
the medium was removed and formazan particles were dissolved
in DMSO. Cell viability, defined as the relative amount of MTT
reduction was determined by spectrophotometry at 570 nm.
Electrophysiological Recordings
Electrophysiological measurements were performed on
pyramidal cells. Action potentials or sodium currents were
recorded at room temperature using whole-cell patch-clampings.
The extracellular solution contained the following (in mM):
NaCl 150, KCl 5, MgCl2 1.1, CaCl2 2.6, HEPES 10, glucose
10, pH adjusted to 7.4 with NaOH. Patch pipettes were made
from borosilicate glass capillaries (1.5mm outer diameter,
0.8mm inner diameter) using a micropipette puller (Narishige,
PP 830, Japan). Pipette resistance ranged from 3 to 5 M.
Stimulation and data acquisition were performed using the
EPC-10 patch-clamp amplifier and Pulse program (HEKA
Electronik, Germany). Membrane currents were filtered at 2 kHz
and digitized at 10 kHz.
Action potentials recordings were made using the current-
clamp mode. The intracellular solution contained the following
(in mM): KCl 65, KOH 5.0, KF 80, HEPES 10, EGTA 10, Na2ATP
2, pH adjusted to 7.2 with KOH. Cells were held at −70mV,
then peak amplitude (80 pA, 10ms), threshold (80 pA, 10ms),
and action potential firing (200 pA, 500ms) were recorded and
measured.
Sodium currents were recorded using the voltage-clamp
mode. The intracellular solution contained the following (in
mM): CsCl 140, MgCl2 2, Na2ATP 2, EGTA 10, HEPES 20,
pH adjusted to 7.2 with Tris-HCl. Cells were held at −70mV
and stepped to a range of potentials (−60 to +60mV in 10mV
Frontiers in Neuroscience | www.frontiersin.org 2 March 2016 | Volume 10 | Article 94
Wang et al. Aβ Modulates Excitability through Nav1.6
increments) for 12ms each. Peak inward currents (I) were plotted
as a function of depolarizing potential to generate I–V curves.
Activation curves were obtained by converting current (I) to
conductance (G) at each voltage (V) using the equation G =
I/(V − Vrev), where Vrev is the reversal potential, which was
determined for each cell individually. Activation curves were
then fit with the Boltzmann function in the form of G/Gmax =
1/{1 + exp [(V1/2 − V)/κ]}, where Gmax is the maximal sodium
conductance, V1/2 is the half-maximal activation potential, V
is the test potential, and κ is the slope factor. Steady-state fast
inactivation was achieved with a series of 500ms prepulses (−120
to −10mV in 10mV increments), and the remaining available
channels were activated by a 12ms test pulse to 0mV. Peak
inward currents obtained from steady-state fast-inactivation
protocols were normalized to the maximal peak current (Imax)
and fit with Boltzmann functions: I/Imax = 1/{1 + exp [(V −
V1/2)/κ]}, where V represents the inactivating prepulse potential,
and V1/2 represents the mid-point of inactivation curve.
Data Analysis
Data were analyzed using Pulsefit 8.6 and Origin 7.5, and
presented as means± SEM. The Kruskal–Wallis non-parametric
test was used to analyze current density data. One-way ANOVA
was used to assess the statistical significance of changes in
characteristics of channel activation and inactivation. Statistical
comparisons were performed by Student’s t-test.
Western Blot
All cells were lysed in RIPA buffer (with 1% PMSF), and total
protein concentrations were determined with a BCA Protein
Assay Kit (TransGen). Total protein (10–20mg) for each sample
was loaded into precast 8% SDS-PAGE gels and run with running
buffer. Gels were transferred onto PVDFmembranes (Millipore).
Antigen-specific primary antibodies (Pan sodium channel,
Chemicon-AB5210; Nav1.6, Chemicon-AB5580 and Abcam-
ab65166; β-tubulin, Abcam-ab6046; β-actin, Abcam-ab6276)
were incubated overnight at 4◦C and detected with species-
specific horseradish-peroxidase-labeled secondary antibodies.
An ECLWestern Blotting Detection kit (TIANGEN) was used to
obtain a chemiluminescence signal, which was detected using Gel
Imaging System (Bio-Rad). Band quantification was performed
using a Gel-Pro software. Bands of interest were normalized to
actin- or tubulin- for a loading control.
RT-PCR
Total RNA of cultured neurons was prepared by using the
Trizol Reagent (Invitrogen, USA). The Superscript TM-III kit
(Invitrogen, USA) was used for reverse-transcribed with oligo
dT and 2.5mg total RNA. Primer sequences were as follows:
NM_019266 (SCN8A), and NM_031144 (β-actin). SCN8A
forward 5′-CTG GAG AAT GGA GGC ACA CAC-3′, reverse 5′-
ACG CTG CTG CTT CTC CTT GTC-3′; and β-actin forward
5′-CGT TGA CAT CCG TAA AGA CCT-3′, reverse 5′-TCA
GGA GGA GCA ATG ATC TTG-3′. The resulting cDNA PCR
amplification was performed by using the following protocol:
95◦C for 10 s followed by 50 cycles of 95◦C for 5 s and 60◦C
for 31 s, and verified by 2.0% agarose gel electrophoresis. Images
were captured by using Gel Imaging System (Bio-Rad). The
amplicon size of each gene was108 and 144 bp, respectively.
Immunofluorescence Staining and
Immunohistochemistry
Cells were fixed with 4% paraformaldehyde for 20min,
permeabilized with 0.1% Triton-x-100 for 5min, and incubated
with 5% BSA for 60min at room temperature to block
non-specific binding. Without washing, the diluted primary
antibodies (MAP2, Abcam-ab32454; Nav1.6, Abcam-ab65166)
were added and incubated at 4◦C overnight. After three
washes with PBS, cells were incubated with the corresponding
secondary antibodies at room temperature for 1 h. For
immunohistochemistry, cells were stained with DAB kit
(Vector Laboratories) according to the instructions of the
manufacturer for peroxidase labeling. Images were acquired
from a fluorescence microscopy (Leica Microsystems DM400B,
Germany).
Image Analysis and Quantification
Quantitative analysis of mean fluorescence intensities (MFIs) of
immunoreactive neurons was performed using Image J software
(National Institutes of Health). MFI per square micrometer was
calculated by dividing the MFI units by the area of outlined
regions.
RESULTS
Elevated Excitability in APP/PS1 Mice
To investigate change in intrinsic excitability in APP/PS1 mice,
whole-cell patch-clamp recordings were performed on 12DIV
(days in vitro) primary cultured neurons obtained from P0
APP/PS1 mice and littermate wide type mice in current-clamp
mode. Frequency, threshold, and peak amplitude of action
potentials (AP) were examined by different protocols. AP
firing frequencies (f) elicited by increasing depolarizing currents
(200 pA, 500ms) were significantly increased in neurons from
APP/PS1 mice compared to WT mice (Figures 1A,D; fWT =
15.375± 3.428Hz, n = 12; fAPP/PS1 = 23.25± 7.264Hz, n = 10;
p = 0.0128). We used a depolarizing current (80 pA, 10ms) to
induce a single firing of an AP. Threshold potential (Vthreshold)
and amplitude of action potential (Vpeak) were recorded and
compared with WT. We found that thresholds of neurons from
APP/PS1 mice were significantly decreased compared to WT
mice (Figures 1B,E; Vthreshold, WT = −29.001 ± 2.304mV, n =
9; Vthreshold, APP/PS1 = −41.601 ±1.965mV, n = 9; p = 0.0012),
but the peak amplitude was not (Figures 1C,F; Vpeak, WT =
46.159 ± 2.663mV, n = 9; Vpeak, APP/PS1 = 47.236 ± 3.849mV,
n = 9; p = 0.6475). These results suggested that the excitability
of mature neurons obtained from APP/PS1 mice was increased.
Aβ1−42 Increases Excitability in Cultured
Cortical Neurons from Mice
It is likely that diverse factors contribute to the pathogenesis of
AD patients or mice (Blennow et al., 2006; Bertram and Tanzi,
2008; Mucke, 2009). Among them, Aβ stands out on the basis
of overwhelming genetic evidence and strong experimental
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FIGURE 1 | Increased neuronal excitability in APP/PS1 mice. (A)
Representative recording traces of action potential repetitive firing. (B) The
schematic of threshold. (C) Representative recording traces of action potential
peak amplitude. (D) The mean number of APs elicited by 200 pA depolarizing
current. Neurons from APP/PS1 mice (n = 10) fired significantly more APs than
WT (n = 12). (E) AP threshold in APP/PS1 mice cultured pyramidal neurons
was significantly lower than WT mice (n = 9 per group). (F) The peak
amplitude of APs in WT and APP/PS1 (n = 9 per group) mice cultured
pyramidal neurons didn’t show significantly difference. Mean ± SEM was
displayed. *Presents p < 0.05; **presents p < 0.01.
data (Farrer et al., 1997; Hardy and Selkoe, 2002; Tanzi and
Bertram, 2005; Mahley and Huang, 2006). Accordingly, we
attempted to investigate whether Aβ1−42 contributed to intrinsic
excitability. Cell viability was firstly determined by MTT assay
in primary cultured neurons treated with 5µM Aβ42−1 or 5µM
Aβ1−42 for 24 h. We found that Aβ1−42 slightly induced loss
of neuron viability (Supplementary Figure S2; n = 3, means
three independent experiments; p = 0.047). As described
previously, whole-cell patch-clamp recordings were performed
in current-clamp mode on normal morphological primary
neurons which were incubated with Aβ1−42 or Aβ42−1 for
24 h. Frequency, threshold, and peak amplitude of AP were
examined. We found AP firing frequencies were significantly
increased in neurons after treatment with Aβ1−42 peptide
compared to controls (Figures 2A,D; fcontrol = 20.25 ±
4.742Hz, n = 8, p = 0.0050; fAβ42−1 = 20.75 ± 4.644Hz,
n = 8, p = 0.0054; fAβ1−42 = 43.25 ± 5.028Hz, n = 8).
Aβ1−42 also significantly decreased the threshold (Figures 2B,E;
Vthreshold, control = − 33.83 ± 1.207mV, n = 7, p = 0.0126;
Vthreshold, Aβ42−1 = −32.55 ± 0.6600mV, n = 7, p = 0.0035;
Vthreshold, Aβ1−42 = −41.37 ± 1.771mV, n = 7). But it had no
effect on the peak amplitude (Figures 2C,F; Vpeak, control = 42.83
FIGURE 2 | Aβ affects neuronal excitability. (A) Representative recording
traces of action potential repetitive firing. (B) The schematic of threshold. (C)
Representative recording traces of action potential peak amplitude. (D) The
mean number of APs elicited by 200 pA depolarizing current. Neurons after
Aβ1−42 treatment (n = 8) fired significantly more APs than controls (both
negative control group and reverse peptide Aβ42−1 group, n = 8). (E) AP
threshold in pyramidal neurons treated with Aβ1−42 (n = 7) was significantly
lower than controls (n = 7). (F) The peak amplitude of APs in pyramidal
neurons treated with Aβ1−42 (n = 7) didn’t show significantly difference with
controls (n = 7). Mean ± SEM was displayed. *Presents p < 0.05 vs. control
group; **presents p < 0.01 vs. control group; ##presents p < 0.01 vs.
Aβ1−42 group.
± 0.9437mV, n = 7, p = 0.6579; Vpeak, Aβ42−1 = 44.60 ±
1.051mV, n = 7, p = 0.5633; Vpeak, Aβ1−42 = 43.58 ± 1.305mV,
n = 7). These results suggested that incubation in Aβ1−42
increases neuronal excitability in vitro.
Increased Neuronal Excitability Induced by
Aβ1−42 Due to an Up-Regulation of Nav
Current
In mammalian neurons, dense clusters of voltage-gated sodium
channels (Nav) at the axonal initial segment and nodes of
Ranvier underlie action potential generation and fast propagation
(Leterrier et al., 2011). In addition, non-inactivating persistent
sodium currents support maintained depolarization during
and between action potentials. Finally, the resurgent persistent
sodium current is triggered upon repolarization and supports
repetitive firing in some types of neurons (Raman et al., 1997).
We therefore hypothesized that the increased excitability induced
by Aβ1−42 could be due, at least in part, to an upregulation of
Nav current. To test this hypothesis, we evaluated the magnitude
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of Nav currents in voltage-clamp mode after incubation with
Aβ1−42 or reverse peptide for 24 h. Representative traces of
the total inward current recorded in response to voltage steps
from −60 to +60mV are shown in Figure 3A. Current density
curves (Figure 3B) and peak current densities (Figure 3C) were
significantly increased after Aβ1−42 treatment compared to
controls (Peakcontrol = 79.18± 11.60 pA/pF, n = 12, p = 0.0028;
PeakAβ42−1 = 74.14 ± 13.54 pA/pF, n = 12, p = 0.0031;
PeakAβ1−42 = 146.3± 10.70pA/pF, n = 12).
We next investigated the effect of Aβ1−42 on sodium channel
kinetic characteristics (Figures 3D,E). We found that Aβ1−42 did
not significantly shift the voltage-dependent sodium activation
curve (Figure 3D). Single Boltzmann distribution fits showed a
V1/2, control = −41.62 ± 1.462mV, and a κ of 4.165 ± 1.548mV
(n = 12); a V1/2, Aβ42−1 = −41.71 ± 1.768mV and a κ of
4.795 ± 1.825mV (n = 12); and a V1/2, Aβ1−42 = −41.19
± 1.052mV and a κ of 4.155 ± 1.184mV (n = 12). For
steady-state inactivation curves (Figure 3E), the V1/2 and κ of
inactivation also did not change significantly (V1/2, control =
−51.47 ± 1.040mV and κ = 6.992 ± 1.017mV, n = 12;
V1/2, Aβ42−1 = −51.90±0.8201mV and κ = 8.384± 0.8552mV,
n = 12; V1/2, Aβ1−42 = −51.40 ± 0.4131mV and κ = 7.723 ±
0.4178mV, n = 12).
Overall, these results demonstrated that exposure of neurons
to Aβ1−42 leads to an increased neuronal excitability, likely
through a Nav current-mediated mechanism.
Increased Expression of Nav in Cultured
Neurons and APP/PS1 Mice
Although, the experiments described above revealed that Aβ1−42
increased neuronal excitability, perhaps dues to increasing Nav
currents, it remained unclear how the Nav currents increased.
There was no observable difference in sodium channel kinetic
characteristics after Aβ1−42 incubation (Figures 3D,E). We then
examined the expression of Nav in neurons after Aβ1−42
treatment. Using Western blot analysis of cultured cortical
neurons, we found that incubation with Aβ1−42 significantly
increased the expression of Nav [Figures 4A,B; n = 3;
pCtrl vs. Aβ1−42 = 0.0146; pAβ42−1 vs. Aβ1−42 = 0.0358]. We
also investigated the Nav1.6 subtype, which plays a major
role in the transmission of subthreshold currents, namely the
persistent and resurgent currents (Raman et al., 1997), and the
electrophysiological properties of Nav1.6 make these channels
especially suited for the sustained repetitive firing of neurons
(Van Wart and Matthews, 2006). As shown in Figures 4C,D,
Nav1.6 displayed a significant increase after Aβ1−42 treatment
FIGURE 3 | Aβ1−42 up-regulates voltage-dependent sodium current. (A) Representative traces of voltage gated sodium currents recorded in response to
voltage steps from −60 to +60mV. (B) Current density-voltage relationship, illustrates that Na+ current density recorded from Aβ1−42 treatment pyramidal neurons
was significantly bigger than counterparts (negative control group and reverse peptide Aβ42−−1 group, n = 12). (C) Graph, data showed peak current density
recorded from Aβ1−42 treatment neurons was significantly bigger than counterparts (n = 12). (D) Normalized steady-state activation curves for Na
+ currents recorded
from cultured pyramidal neurons after Aβ1−42 treatment and counterparts (n = 12). The activation curves were not significantly shift after Aβ1−42 treatment. (E)
Normalized steady-state inactivation curves for Na+ currents recorded from these three groups, and the inactivation curve was not significantly shift after Aβ1−42
treatment either. Mean ± SEM was displayed. **Presents p < 0.01 vs. Aβ1−42 group;
##presents p < 0.01 vs. Aβ1−42 group.
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FIGURE 4 | Aβ1−42 increases the expression of sodium channels. (A) Equal amounts of collected protein samples obtained from 12DIV neurons after different
treatments were analyzed by western blot to detect the protein expression level of sodium channel (n = 3 per group). (B) Quantification of protein levels of sodium
channel. β-actin was used as an internal control (n = 3 per group). (C) Western blots of 12DIV neurons after different treatments to detect the expression of Nav1.6
protein (n = 3 per group). (D) Quantification of protein levels of Nav1.6. β-tubulin was used as an internal control (n = 3 per group). (E) RT-PCR of Nav1.6 mRNA levels
of 12DIV neurons after different treatments (n = 3 per group). (F) Quantification of mRNA levels of Nav1.6. β-actin was used as an internal control (n = 3 per group).
Mean ± SEM was displayed. *Presents p < 0.05 vs. Aβ1−42 group; #presents p < 0.05 vs. Aβ1−42 group.
[n = 3; pCtrl vs. Aβ1−42 = 0.0372; pAβ42−1 vs. Aβ1−42 =
0.0354]. To further identify the increased expression of Nav1.6
after Aβ1−42 treatment, mRNA expression levels were detected
too. Paralleled with western blot analysis, Nav1.6 mRNA
obtained from cultured neurons treated with Aβ1−42 showed
significantly increased than control groups [Figures 4E,F,
n = 3; pCtrl vs. Aβ1−42 = 0.0257; pAβ42−1 vs. Aβ1−42 =
0.017].
Morphological methods were also used to test the expression
of Nav1.6. The localization of Nav1.6 in neurons was revealed by
immunohistochemistry (Figure 5A). Consistent with the result
from western blotting, most neurons incubated with Aβ1−42
showed significantly deepening stain [Figures 5A,C; n = 3;
pCtrl vs. Aβ1−42 = 0.0162]. After obtaining these results, we
wondered if the expression of Nav1.6 in APP/PS1 mouse
brains would have changed. Coronal brain sections from 9
month old APP/PS1 mice and WT littermates were stained for
MAP2, a maker of mature neurons, and Nav1.6 (Figure 5B;
n = 3). We found, that APP/PS1 mice exhibited more Nav1.6
immunoreactivity than WT mice in cortex regions (Figure 5D;
n = 3; p = 0.0286).
Taken together, our findings and previous studies suggest that
Aβ1−42 increased the excitability of cultured cortical neurons,
and this effect was mediated by overexpression of Nav, with the
Nav1.6 subtype perhaps accounting for much of this increase.
DISCUSSION
In addition to cognitive deficits, AD patients have an increased
incidence of epileptic seizures. This incidence is even higher in
patients with early-onset AD who overexpress human APP, the
proteolysis of which generates Aβ (Palop and Mucke, 2009).
Hyperexcitability is also detected in the brains of various AD
transgenic mice (Tamagnini et al., 2015), including the APP/PS1
mice used here. Such aberrant increases in network excitability
and compensatory inhibitory mechanisms in the hippocampus
may contribute to the cognitive deficits in AD (Palop et al.,
2007; Sanchez et al., 2012; Verret et al., 2012). However, the
mechanisms underlying the hyperexcitability detected in AD
brains are not fully understood.
In the present study, we investigated the excitability in
cultured pyramidal neurons of APP/PS1 mice using patch clamp
techniques. We found that the excitability of 12DIV cultured
pyramidal neurons from APP/PS1 mice was significantly greater
than in WT littermates. Additionally, AP firing frequencies
increased and Vthreshold decreased in neurons from APP/PS1
mice compared to WT mice. These results confirm previous
studies that showed neuronal hyperexcitability in APP/PS1
mice by patch clamp methods. In recent years, many studies
demonstrated that Aβ is associated with increased excitability
of neurons in vitro and in animal models, leading to
hypersynchronous network activity and higher risk for seizures
(Minkeviciene et al., 2009; Busche et al., 2012; Born et al.,
2014; Davis et al., 2014). In our current work, we observed the
altered excitability of pyramidal neurons after treatment with Aβ.
The higher firing frequency and lower threshold indicated an
increased intrinsic excitability of pyramidal neurons.
Aβ-induced aberrant excitatory activity might occur through
many different mechanisms. Previous studies have shown that
Aβ can downregulate A-type K+ currents, thereby increasing
excitability of hippocampal pyramidal neurons (Good and
Murphy, 1996; Chen, 2005). Elevated Aβ also causes GABAergic
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FIGURE 5 | Elevated expression of Nav1.6 in cultured neurons and APP/PS1 mice. (A) Immunohistochemistry images of 12DIV primary cortical culture
neurons after 24 h Aβ42−1 or Aβ1−42 treatments stained with anti-Nav1.6 antibody. Scale bar = 50µm (n = 3 per group). (B) Immunostaining images of temporal
lobe cortex sections obtained from 9 months APP/PS1 mice and its littermates co-stained with anti-Nav1.6 antibody and anti-MAP2 antibody (n = 3 per group).
(C) Quantification of Nav1.6 immunohistochemistry images by using intensity analysis (n = 3 per group). (D) Quantification of fluorescence intensity of Nav1.6 (n = 3
per group). Mean ± SEM was displayed. *Presents p < 0.05 vs. control group.
dysfunction and attenuates excitatory synaptic transmission by
decreasing the number of surface AMPA and NMDA receptors
(Kamenetz et al., 2003; Hsieh et al., 2006; Shankar et al., 2007),
as well as disrupting the development of aberrant synchrony
in neural networks, damaging cognitive functions. Subsequent
studies proved that neuronal activity regulates Aβ production
(Kamenetz et al., 2003; Cirrito et al., 2005). Blocking neuronal
electrical activity with TTX, a sodium channel blocker, decreased
the cleavage of APP by β-secretase (Kamenetz et al., 2003). Recent
studies found that blocking the network hyperactivity with the
anti-epileptic drug lamotrigine, a voltage-dependent sodium
channel inhibitor, reversed synaptic disorder and cognitive
dysfunction in APP transgenic mice (Bakker et al., 2012; Sanchez
et al., 2012; Zhang et al., 2014). These results indicate that Aβ,
or other AD-related factors, plays a significant role in regulating
neuronal activity at specific types of neurons as well as in wider
neuronal networks, and Aβ and sodium channels have a certain
relationship.
Voltage-dependent sodium currents play a critical role in
action potential depolarization and firing frequency in many
types of neurons (Kim et al., 2005; Baroni et al., 2013). We
therefore hypothesized that the increased excitability induced
by Aβ1−42 could be due, at least in part, to an upregulation
of the Nav current. As we expected, the peaks of the voltage-
dependent sodium current were significantly increased after
Aβ1−42 treatment. The increased voltage-dependent sodium
current could decrease action potential threshold and increase
the probability of action potential generation in response to
synaptic excitation, thus increasing the excitability of the neuron.
However, Aβ upregulated sodium currents without significantly
altering the voltage-dependence of activation and inactivation.
We found that Aβ increased the expression of Nav and Nav1.6
in cultured neurons, indicating that the number of Nav channels
could be altered by Aβ1−42. These results provide a possible
mechanism for the increased excitability of pyramidal neurons
previously observed after Aβ treatment. Confirming the causal
relationship between the aberrant excitatory activity induced by
Aβ and cognitive decline in AD patients would be an important
insight into the pathogenesis of AD and provide new therapeutic
avenues.
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Supplementary Figure S1 | Biochemical characterization of Aβ1−42. Eighty
nanogram aged Aβ1−42 and Aβ1−42 monomer samples were analyzed by
SDS-PAGE and detected with anti-6E10 antibody. After 48 h aggregated Aβ1−42
with different molecular weight forms were displayed. aged presents Aβ1−42 with
aggregation treatment; mono presents Aβ1−42 monomer.
Supplementary Figure S2 | Cell viability measurement of neuron treated
with Aβ1−42. Cell viability was determined by MTT assay in primary cultured
neurons treated with 5µM Aβ42−1 or 5µM Aβ1−42 for 24 h. Aβ1−42 induced
slightly loss of cell viability in neurons. (n = 3, means 3 independent experiments).
Mean ± SEM was displayed. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide. *Presents p < 0.05 vs. control group.
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